Forecast & Rating4 analysts currently cover Adial Pharmaceuticals, of which 3 give a positive rating. The average price target is $8.33, about 34.1% upside from the current price of $6.22. Coverage is limited, so the data is for reference only. Data as of Aug 3, 2026; this does not constitute investment advice.
Aug 3, 2026Price forecast
$8.3334.08%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy25.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$6.22
Avg. target$8.3
High target$11
Low target$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.